Back to search
FDAFDA · Food and drugs·Recall number D-0473-2022

Ephedrine Plus (Ephedrine HCl 25mg, Guaifenesin 200mg) tablets, 24-count bottles, Marketed by: DMD Pharmaceuticals A Division of Dickery Consumer Products, Inc. Noblesville, IN 46060, NDC 65193-320-24

Published February 9, 2022 · Recall initiated: January 24, 2022

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP deviations

What to do

Voluntary: Firm initiated · Letter

Recall details

Manufacturer
Ultra Seal Corporation
Distributor
Nationwide within the United States
Lot
Lot#: 18M063, Exp. Date 01/2022; 19G076, Exp. Date 09/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card